255 related articles for article (PubMed ID: 18562416)
1. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder.
Koesters M; Becker T; Kilian R; Fegert JM; Weinmann S
J Psychopharmacol; 2009 Sep; 23(7):733-44. PubMed ID: 18562416
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder.
Faraone SV; Spencer T; Aleardi M; Pagano C; Biederman J
J Clin Psychopharmacol; 2004 Feb; 24(1):24-9. PubMed ID: 14709943
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis.
Van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Rev; 2008 Jun; 28(5):783-800. PubMed ID: 18068284
[TBL] [Abstract][Full Text] [Related]
5. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
[TBL] [Abstract][Full Text] [Related]
6. [Neuropsychological assessment of the effectiveness of OROS-methylphenidate in attention deficit hyperactivity disorder].
Rubio-Morell B; Martín-González R; Herreros-Rodríguez O; González-Pérez P; Hernández-Exposito S; Quintero-Fuentes I; Gracia-Marco R
Rev Neurol; 2008 May 16-31; 46(10):602-8. PubMed ID: 18465700
[TBL] [Abstract][Full Text] [Related]
7. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder.
Snyder SM; Hall JR
J Clin Neurophysiol; 2006 Oct; 23(5):440-55. PubMed ID: 17016156
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
10. Improving decision making in the treatment of ADHD.
Vitiello B
Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
[No Abstract] [Full Text] [Related]
11. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.
Rostain AL
Postgrad Med; 2008 Sep; 120(3):27-38. PubMed ID: 18824823
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
Pan XX; Ma HW; Wan B; Dai XM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164
[TBL] [Abstract][Full Text] [Related]
13. Treatment effectiveness of combined medication/behavioural treatment with chinese ADHD children in routine practice.
So CY; Leung PW; Hung SF
Behav Res Ther; 2008 Sep; 46(9):983-92. PubMed ID: 18692170
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial.
Verster JC; Bekker EM; de Roos M; Minova A; Eijken EJ; Kooij JJ; Buitelaar JK; Kenemans JL; Verbaten MN; Olivier B; Volkerts ER
J Psychopharmacol; 2008 May; 22(3):230-7. PubMed ID: 18308788
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis.
Castells X; Ramos-Quiroga JA; Rigau D; Bosch R; Nogueira M; Vidal X; Casas M
CNS Drugs; 2011 Feb; 25(2):157-69. PubMed ID: 21254791
[TBL] [Abstract][Full Text] [Related]
16. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
Olfson M; Marcus SC; Zhang HF; Wan GJ
J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
[No Abstract] [Full Text] [Related]
17. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
18. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
19. Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.
Cheon KA; Cho DY; Koo MS; Song DH; Namkoong K
Biol Psychiatry; 2009 Apr; 65(7):564-70. PubMed ID: 19150055
[TBL] [Abstract][Full Text] [Related]
20. [Effects and mechanisms of psychotherapy in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults].
Philipsen A; van Elst LT; Lesch KP; Jans T; Warnke A
Psychother Psychosom Med Psychol; 2009; 59(3-4):132-40. PubMed ID: 19350473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
